SEARCH RESULTS FOR:

tosk

Brian Frenzel

PRESIDENT & CEO, TOSK
United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.

Brian Frenzel

CEO, TOSK
Tosk is developing a family of small molecule drugs to prevent the toxic side ef-fects of cancer treatments.

Brian Frenzel

PRESIDENT AND CEO, TOSK, INC.
United States Biopharmaceuticals 2018
Tosk, Inc. is a small molecule, oncology drug discovery and development company.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

MACIG 2025 - Mining in Africa Country Investment Guide

It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.

PARTNER EVENTS